Ledipasvir Impurity 10 CAS CATO-C4X-331310
| CAS No. | CATO-C4X-331310 |
| Molecular Formula | C13H14BrN3 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The molecular framework of Ledipasvir Impurity 10 (C13H14BrN3HCl) is characterized by a nitrogen-containing heterocyclic scaffold, a nitrile group, chlorine/bromine substitution. In reversed-phase chromatography, its retention is governed primarily by its high hydrophobicity (logP), which provides a practical basis for HPLC-UV/DAD or LC-MS method development. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
As a process- or degradation-related impurity, Ledipasvir Impurity 10 (CAS CATO-C4X-331310, C13H14BrN3HCl) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Ledipasvir Impurity 10 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C13H14BrN3 2*HCl |
| Molecular Weight | 328.64 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 7.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl/Br-containing |
| Nitrogen Atoms | 3 |
Related Ledipasvir Standards
- Ledipasvir Impurity-3 (CAS 1256388-50-7)
- Ledipasvir (CAS 1256388-51-8)
- Ledipasvir Intermediate (CAS 1256393-27-7)
- Ledipasvir impurity 1 (CAS 134877-62-6)
- Ledipasvir Impurity 7 (CAS 1441670-89-8)
- Ledipasvir Acetone (CAS 1441674-54-9)
- Ledipasvir Impurity 8 (CAS 1499193-65-5)
- Ledipasvir D-tartrate (CAS 1502654-87-6)
Recommended Standards
- Sarecycline Impurity 2 (CAS CATO-C4X-27982)
- Mirogabalin Impurity 10 (CAS CATO-C4X-292410)
- Difelikefalin Impurity 93 (CAS CATO-C4X-304193)
- tert-Butyl (2-oxo-2,5-dihydrofuran-3-yl)carbamate (CAS 144704-77-8)
- 3-(2-Fluorophenyl)-1H-pyrazole-5-carboxylic acid (CAS 859155-87-6)
- 1,7-Dimethyl-1H-imidazo[1,2-b]pyrazole (CAS 135830-03-4)
- 7-Fluoro-1-indanone, 97% (CAS 651735-59-0)
- N'-Hydroxy-1H-benzimidazole-5-carboximidamide (CAS 939999-63-0)
- 3-(((5-Methylthiophen-2-yl)methyl)amino)thietane 1,1-dioxide (CAS 1879200-77-7)
- Semaglutide Impurity 133 (CAS CATO-C4X-2226133)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com